跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
艾力雅 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Aflibercept Intravitreous Injection
Approved
生物制品
Aflibercept Intravitreous Injection
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
May 19, 2025
Approval ID
8jhFVUar1oi
Company
BAYER AG
Type
生物制品
Approval Details
Approval Id
8jhFVUar1oi
Approval Number
国药准字SJ20255004
Generic Name
阿柏西普眼内注射溶液
Generic Name En
Aflibercept Intravitreous Injection
Trade Name
艾力雅
Drug Type
生物制品
Dosage Form
注射剂
Strength
114.3mg/mL (70µl含有8mg阿柏西普)
Reg Date
2025-05-19
Expired Date
2028-04-09
Company Name
BAYER AG
Production Company Name
Catalent Indiana, LLC
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/catalent-indiana-llc-bloomington-indiana-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 19, 2025
Approval ID
8jhFVUar1oi
Type
生物制品
Back to NMPA Approvals